Will Immune Checkpoint Inhibitors Allow the Non-operative Management of Mismatch Repair-deficient Colorectal Cancer to Become a Standard of Care?

Clin Oncol (R Coll Radiol). 2024 Mar;36(3):136-140. doi: 10.1016/j.clon.2024.01.006. Epub 2024 Jan 14.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Colonic Neoplasms*
  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / genetics
  • DNA Mismatch Repair / genetics
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Standard of Care

Substances

  • Immune Checkpoint Inhibitors